alginic acid 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4321 9005-32-7

Description:

MoleculeDescription

Synonyms:

  • alginic acid
A polysaccharide and linear copolymer, consisting mainly of beta-1,4-linked D-mannuronic acid and alpha-1,4-linked L-glucuronic acid, that occurs in marine algae such as LAMINARIA, and in BIOFILMS produced by PSEUDOMONAS AERUGINOSA.
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Carbuncle 118.77 62.92 20 1215 1416 90625796
Monoclonal immunoglobulin present 110.95 62.92 20 1215 2104 90625108
Hypothalamo-pituitary disorder 109.79 62.92 20 1215 2232 90624980
Wrist deformity 102.54 62.92 20 1215 3218 90623994
Overweight 90.46 62.92 20 1215 5914 90621298
Fibrosis 90.40 62.92 20 1215 5932 90621280
Nephropathy 81.66 62.92 20 1215 9215 90617997
Dyslipidaemia 79.86 62.92 20 1215 10087 90617125
Body height decreased 76.54 62.92 20 1215 11929 90615283
Renal cyst 74.94 62.92 20 1215 12930 90614282
Purpura 72.33 62.92 20 1215 14758 90612454
Bone density decreased 69.16 62.92 20 1215 17325 90609887

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Carbuncle 108.80 61.15 20 2401 1447 110585431
Monoclonal immunoglobulin present 97.84 61.15 20 2401 2520 110584358
Hypothalamo-pituitary disorder 95.57 61.15 20 2401 2826 110584052
Wrist deformity 93.31 61.15 20 2401 3169 110583709
Catarrh 91.45 61.15 23 2398 7312 110579566
Burns second degree 90.25 61.15 23 2398 7710 110579168
Steroid dependence 88.17 61.15 23 2398 8446 110578432
Alcohol poisoning 81.99 61.15 22 2399 8998 110577880
Hypopnoea 81.44 61.15 23 2398 11357 110575521
Overweight 79.25 61.15 20 2401 6444 110580434
Parosmia 78.10 61.15 23 2398 13157 110573721
Fibrosis 75.92 61.15 20 2401 7622 110579256
Gingival pain 74.08 61.15 23 2398 15713 110571165
Body height decreased 69.51 61.15 20 2401 10543 110576335
Rhinitis 65.96 61.15 23 2398 22522 110564356
Nephropathy 64.72 61.15 20 2401 13447 110573431
Arthritis 64.36 61.15 42 2379 167544 110419334
Cardiac murmur 63.97 61.15 23 2398 24605 110562273
Dyslipidaemia 61.37 61.15 20 2401 15945 110570933
Bone density decreased 61.27 61.15 20 2401 16022 110570856

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A02BX13 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
CHEBI has role CHEBI:35480 analgesic
CHEBI has role CHEBI:49201 anti-ulcer drug
CHEBI has role CHEBI:50248 hematologic agent
CHEBI has role CHEBI:74518 anti-obesity agent

Related Drugs by ATC class:

A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) 15 drugs
acetoxolonebismuth subcitratebismuth subnitratecarbenoxolonegefarnateirsogladinemethiosulfonium chloridepirenzepineproglumiderebamipidesucralfatesulglicotide show all 15 →

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4019383 VUID
N0000179032 NUI
D02324 KEGG_DRUG
4019383 VANDF
C0051156 UMLSCUI
CHEBI:17548 CHEBI
CHEMBL2108894 ChEMBL_ID
D000077322 MESH_DESCRIPTOR_UI
DB13518 DRUGBANK_ID
8C3Z4148WZ UNII
17305 RXNORM
7454 MMSL
d05227 MMSL
002434 NDDF
391734004 SNOMEDCT_US
412571008 SNOMEDCT_US

Pharmaceutical products:

None